Technical Comparison
NVIDIA Corporation - Common Stock vs PharmaCyte Biotech, Inc. - Common Stock
Real-time financial comparison matrix between NVDA and PMCB.
Primary Asset
NVD
NVIDIA Corporation - Common Stock
Market Rank #101Live Price$200.13
Market Capitalization$4.8T
24h Change-3.17%
Circulating Supply24B NVDA
Comparison Asset
PMC
PharmaCyte Biotech, Inc. - Common Stock
Market Rank #1003826Live Price$0.38
Market Capitalization$4.1M
24h Change+12.03%
Circulating Supply11M PMCB
Market Metric Matrix
| Comparison Metric | NVDA Value | PMCB Value | Dominant Asset |
|---|---|---|---|
| Market Cap Rank | #101 | #1003826 | NVIDIA Corporation - Common Stock |
| Unit Price Valuation | $200.13 | $0.38 | NVIDIA Corporation - Common Stock |
| Total Liquid Cap | $4.8T | $4.1M | NVIDIA Corporation - Common Stock |
Frequently Asked Questions
Is NVIDIA Corporation - Common Stock bigger than PharmaCyte Biotech, Inc. - Common Stock?
NVIDIA Corporation - Common Stock has a market cap of $4.8T, while PharmaCyte Biotech, Inc. - Common Stock sits at $4.1M. Therefore, NVIDIA Corporation - Common Stock is currently the larger financial asset by market capitalization.
What is the price ratio between NVIDIA Corporation - Common Stock and PharmaCyte Biotech, Inc. - Common Stock?
Currently, 1 NVDA is worth 525.28 PMCB.